Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00103-013-1803-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epidemiology of measles clusters/outbreaks during 2016-2017 in Oman.
IJID Reg
March 2025
Director General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman.
Objectives: The epidemiology of measles in Oman has shown a decreasing trend since the introduction of vaccines with high coverage, even at the district level. Oman achieved elimination status in 2019. Currently, measles epidemiology is characterized by a small number of imported and importation-related cases with limited spread in the community.
View Article and Find Full Text PDFGenetic characterization of measles virus circulating in Iran, 2021-2023.
BMC Infect Dis
January 2025
Department of Virology, School of Public Health, National Measles Laboratory (NML), Tehran University of Medical Sciences, Tehran, Iran.
Background: Measles, an ongoing public health concern, demands continuous molecular surveillance and virus characterization for elimination. Despite Iran achieving measles elimination status in 2019 through robust molecular testing and vaccination, the COVID-19 pandemic disrupted global vaccination efforts, leading to increased measles-related morbidity and mortality. This study aims to overview measles virus serological and molecular traits in Iran from 1st January 2021 to 30th April 2023.
View Article and Find Full Text PDFCorrigendum to "Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 - June 2024" [Vaccine 46C (2025) 126681].
Vaccine
January 2025
National Sustainability Committee for the Elimination of Measles, Rubella, and Congenital Rubella Syndrome (NSC), United States of America.
Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles elimination.
Lancet Reg Health Southeast Asia
January 2025
Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Background: In highly measles immunized countries, immunity gaps in adolescents and young adults are a key issue posing an obstacle to measles elimination. This study aims to identify the gaps by estimating the age-stratified probability of seropositivity, and to ascertain a suitable age for the administration of a third dose of a measles-containing vaccine (MCV3) to effectively fill these gaps.
Methods: We retrospectively obtained measles serological results from hospital setting among among individuals aged 13-39 years and developed a serocatalytic dynamic probability model, stratifying seropositivity due to vaccination or natural infection.
Recent Increase in Measles Cases Threatens Elimination Status in United States.
MCN Am J Matern Child Nurs
August 2024
Judy A. Beal is a Professor and Dean Emerita in the College of Natural, Behavioral, and Health Sciences at Simmons University, Boston, MA, and an MCN Editorial Board Member. Dr. Beal can be reached at
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!